Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...

Tens of thousands of people with the most aggressive type of heart disease could die as a result of insufficient diagnostic tests, experts have warned.

Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...

InterShunt Technologies announced today that it began an early feasibility study of its device for reducing heart failure symptoms.

Patients were screened from both a single cardiologist practice and a specialty heart failure (HF) clinic and were included ... making both interventions viable and better than treatment as usual. Our ...

“Thankfully, we’ve made progress in better identifying patients and administering treatment quickly, so they’re living longer, but they then develop the secondary consequence of progressive heart ...

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...

The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the ...

HonorHealth Research Institute clinical trial, using non-surgical techniques, showed 86% of patients with a type of usually ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

U.S. heart disease mortality has dropped 66% since 1970, mainly due to fewer ischemic heart disease deaths. However, deaths ...

Research shows heart attack deaths have plummeted by nearly 90% since 1970, while deaths from heart failure and arrhythmias ...